Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- NOI GETS FDA CLEARANCE FOR TRIAL OF BONE GROWTH STIMULATOR.
- National Osteoporosis Institute NOI and Orthofix International N.V. (Nasdaq: OFIX) have announced that NOI has received clearance from the U.S. Food and Drug Administration to begin a clinical trial with Orthofix's Bone Growth Stimulator for the treatment of osteoporosis. As required by the FDA, the trial...
- Research articles 2000-01-01
Additional Resources
- US DEPT OF HHS: New NIAMS grant targets osteoporosis inin men.
- M2 PRESSWIRE-15 October 1999-US DEPT OF HHS: New NIAMS grant targets osteoporosis in men C1994-99 M2 COMMUNICATIONS LTD RDATE:151099 Osteoporosis, the major bone-weakening and fracture-causing disease which has long been studied in women, will now undergo major scrutiny in men with...
- Research articles 1999-10-15
- -U.S. HHS: Osteoporosis Resource Center receives NIAMS funding.
- M2 PRESSWIRE-14 October 1998-U.S. HHS: Osteoporosis Resource Center receives NIAMS funding C1994-98 M2 COMMUNICATIONS LTD RDATE:131098 The NIH Osteoporosis and Related Bone Diseases~National Resource Center, which will amass, develop and disseminate information on a variety of bone disorders, was funded on...
- Research articles 1998-10-14
- << Previous
- page 1 of 1
- Next >>